Human medicines European public assessment report (EPAR): Nuvaxovid, COVID-19 Vaccine (recombinant, adjuvanted), COVID-19 virus infection, Date of authorisation: 20/12/2021, Revision: 11, Status: Authorised

Withdrawn application: Gefzuris, gefapixant, Date of withdrawal: 14/07/2023, Initial authorisation

Human medicines European public assessment report (EPAR): VidPrevtyn Beta, COVID-19 Vaccine (recombinant, adjuvanted), COVID-19 virus infection, Date of authorisation: 10/11/2022, Revision: 1, Status: Authorised

First electronic product information (ePI) published for selected human medicines

Maximum residue limits (MRL)

Availability of veterinary vaccines

Union Product Database

Advice on impacts of using antimicrobials in animals

European Surveillance of Veterinary Antimicrobial Consumption (ESVAC)

Human medicines European public assessment report (EPAR): Relvar Ellipta, fluticasone furoate,vilanterol, Pulmonary Disease, Chronic Obstructive, Date of authorisation: 13/11/2013, Revision: 25, Status: Authorised